Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.India-based companies Cipla and Hetero have separately launched remdesivir, which has been licensed from Gilead Sciences, for the treatment of Covid-19 in the country.
Cipla introduced the drug in India under the brand name CIPREMI. The company received approval from the Drug Controller General of India (DCGI) for restricted emergency use of the drug in the country.
The company intends to commercialise CIPREMI via its own facilities and partnered sites. The drug will be supplied through the government, as well as open market channels.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.